VBIO Insider Trading Activity and SEC Form 4 Filings
VBIO insider trading summary
No open-market insider purchases or sales of Vitality Biopharma, Inc. (VBIO) have been reported on SEC Form 4 in the past 12 months.
Latest VBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 29, 2021 | Joseph E. LoConti | 10% Owner | Buy | $200 (1,000 @ $0.20) |
| Jul 20, 2021 | Joseph E. LoConti | 10% Owner | Buy | $3K (13,000 @ $0.20) |
| Jul 19, 2021 | Joseph E. LoConti | 10% Owner | Buy | $13K (67,000 @ $0.19) |
| Jul 19, 2021 | Joseph E. LoConti | 10% Owner | Buy | $6K (40,000 @ $0.16) |
| Jul 19, 2021 | Joseph E. LoConti | 10% Owner | Buy | $4K (20,000 @ $0.20) |
| Jul 9, 2021 | Joseph E. LoConti | 10% Owner | Buy | $4K (20,000 @ $0.19) |
| May 11, 2021 | Joseph E. LoConti | 10% Owner | Buy | $2K (10,000 @ $0.17) |
| May 11, 2021 | Joseph E. LoConti | 10% Owner | Buy | $2K (10,000 @ $0.18) |
| Feb 5, 2021 | Brandon Joel Zipp | Chief Science Officer | Buy | $4K (19,071 @ $0.19) |
| Feb 4, 2021 | Brandon Joel Zipp | Chief Science Officer | Buy | $5K (30,929 @ $0.17) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.